Keywords: oxxon, starts, melanoma, vaccine, trials, uk, biotechnology

Oxxon starts melanoma vaccine trials

Article | 30 May 2001

Print This

UK biotechnology firm Oxxon Pharmaccines has initiated a Phase I trialof a therapeutic vaccine (pharmaccine) for melanoma in the UK, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in